M-M-R^®_II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.

—M-M-R^®_II should be given 1 month before or after administration of other live viral vaccines.

Select Safety Information

M-M-R^®_II is contraindicated in certain individuals, including those with: a history of hypersensitivity to any component of the vaccine, including gelatin; a history of anaphylactic or anaphylactoid reaction to neomycin; blood dyscrasias, leukemia, lymphomas of any type, or other malignant neoplasms affecting the bone marrow or lymphatic systems; an immunodeficient condition or receiving immunosuppressive therapy; an active febrile illness; or those who are pregnant.

Due caution should be employed in administration of M-M-R^®_II to persons with a history of cerebral injury, individual or family histories of convulsions, or any other condition in which stress due to fever should be avoided.

The following adverse reactions have been reported with M-M-R^®_II without regard to causality: fever, headache, dizziness, rash, injection-site reactions, febrile convulsions, anaphylaxis and anaphylactoid reactions, arthritis, and thrombocytopenia.

As for any vaccine, vaccination with M-M-R^®_II may not result in protection in 100% of vaccinees.

Before administering M-M-R^®_II, please read the Prescribing Information.

M-M-R^®_II is a registered trademark of Merck & Co., Inc.